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Abstract
Purpose To report the course of ataxia in children up to 2 years post-operatively, following surgical resection of a posterior fossa 
tumour (PFT).
Methods Thirty-five children, (median age 9 years, range 4–15) having resection of PFT, were assessed using the Scale for the 
Assessment and Rating of Ataxia (SARA), Brief Ataxia Rating Scale (BARS) and the mobility domain of the Paediatric Evalu-
ation of Disability Index (PEDI-m) at initial post-operative period (baseline), 3 months, 1 year and 2 years post-operatively.
Results Baseline median scores of the SARA and BARS were 8.5 (range 0–35.5), and 7 (0–25) respectively. Ataxia improved 
at 3 months (median SARA and BARS reduction 3.5 and 4, respectively). Additional gradual improvements in SARA were 
recorded at 1 (median reduction 2) and 2 years post-operatively (median reduction 0.5). Median baseline PEDI-m was 54.75 
(range 15.2–100) with improvement at 3 months (median increase 36.95) and small improvement at 1 year (median increase 
2.5) and 2 years (median increase 5.8). Children with medulloblastoma and midline tumours (median baseline SARA 10 
and 11, respectively) demonstrated more severe ataxia than children with low-grade gliomas and unilateral tumours (median 
baseline SARA 7.5 and 6.5, respectively).
Conclusion The largest improvement in ataxia scores and functional mobility scores is demonstrated within the first 3 months 
post-operatively, but ongoing gradual improvement is observed at 2 years. Children with medulloblastoma and midline 
tumour demonstrated higher ataxia scores long term.
Keywords Paediatrics · Cerebellum · Rehabilitation
Introduction
Posterior fossa tumours (PFT) account for approximately 
50% of all childhood brain tumours [1]. Management of PFT 
typically involves surgical resection, solely or in combination 
with adjuvant treatments such as radiotherapy and chemo-
therapy [2].
Ataxia is the predominant motor problem in children 
with PFT. Ataxia describes a number of related impairments 
including limb incoordination, tremor, gait disturbance, 
impaired balance and oculomotor and oromotor dysfunction 
[3]. Approximately 60% of children with PFT demonstrate 
ataxia pre-operatively [4]. The severity and incidence of 
ataxia may increase post-operatively [5].
Evolving evidence indicates that ataxia can persist in the 
long term in children with PFT. Robertson et al. [5] presented 
initial work in this area observing that children with severe 
ataxia at 1 month post-operatively continued to have ataxia at 
1 year after surgery. Sønderkær et al. [6] reported that ataxia 
may persist at 10 years after surgery. More recent report-
ing with standardised outcome measures has also observed 
approximately 70% [7, 8] of children with PFT which demon-
strate balance dysfunction more than 1 year following surgery.
Risk factors for ataxia are less well described than for other 
toxicity such as cerebellar mutism syndrome, where invasion 
of the brainstem is known to be a risk factor [5], and potential 
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for reduction in risk of ataxia has not been widely explored. 
Kuper et al. [9] presented one of the few studies with lon-
gitudinal data, describing the recovery of 12 children with 
cerebellar tumour from the early post-operative period to reas-
sessment at 3 months and 1 year. They noted ongoing recov-
ery throughout the first year, although children with injury to 
the deep cerebellar nuclei had persistent impairment. These 
findings support the earlier cross-sectional study by Konzcak 
et al. [10].
In this paper, we present a new insight into the longitudinal 
course of ataxia and functional mobility using standardised 
measures in children with PFT from the peri-operative period, 
initial post-operative period and up to 2 years post-operatively. 
Additionally, we explore the impact of tumour location, histol-
ogy and adjuvant treatment on severity of ataxia.
Methods
Design
Cohort prospective single site longitudinal study.
Participants
Children who had surgical resection of a PFT and were aged 
between 4 and 18 years (inclusive) were eligible for inclusion. 
Due to the need to be able to follow the instructions required 
for assessment of ataxia, the lower age limit was set as 4 years 
old.
Procedures
Children were recruited from a single tertiary neurosurgical/
oncology unit in the UK between 2012 and 2018. The study 
was approved by the relevant local ethics and research and 
development committee (IRAS ID98449).
Potential participants were identified and screened for eligi-
bility by the neurosciences therapy team. Informed and written 
consent was obtained from all children and/or their parents 
(with child assent).
Children were assessed initially as an inpatient within 1 
week of surgical resection (baseline) and then in an outpatient 
clinic setting at 3 months, 1 year and 2 years post-operatively. 
Assessments were completed by a neuro-physiotherapist 
trained in the use of the standardised outcome measures. A 
subset of participants was also assessed pre-operatively; this 
occurred if children were stable pre-operatively and where 
timing of admission and surgery allowed for pre-operative 
assessment.
Ataxia outcome measures
Children were assessed using the Scale for the Assessment 
and Rating of Ataxia (SARA scale) [11] and the Brief Ataxia 
Rating Scale (BARS scale) [12]. The SARA and the BARS 
are reliable and valid measures of ataxia for children with 
PFT [13]. The SARA is used in clinical paediatrics and has 
age-based normative reference values [14]. It has 8 items 
and has a total score out of 40, with a higher score indicating 
more severe ataxia. Three items of the SARA (gait, stance 
and sitting, total 18) have been deemed the Bal-SARA [15] 
and particularly represent balance impairment. The BARS 
has 5 items and is scored out of 30; a higher score indicates 
more severe ataxia. Both scales are quick and easy to use 
based on a standard clinical examination of ataxia.
The mobility domain of the Paediatric Evaluation of Dis-
ability Index (PEDI) was also used as a functional mobility 
measure [16]. The PEDI is a valid and reliable functional 
measure in children with acquired brain injury (validated from 
6 months to 7 years, although it can be used in older children 
with functional difficulties) [16]. It has self-care, mobility and 
social function sections which can be used as a whole or as 
stand-alone domains. It is completed by the therapist or by 
parental questioning. Only the mobility domain of the PEDI 
(PEDI-m) was collected to minimise time burden of assess-
ment for the participants. A higher PEDI-m score (range 0 to 
100) represents a better level of physical function and corre-
lates with lower overall measures of disability.
Baseline disease descriptors
Baseline potential predictive factors of severity of ataxia were 
collected including tumour histology, age at diagnosis, adju-
vant treatment (radiotherapy or chemotherapy), tumour loca-
tion and surgical approach.
Data analysis
The study was not designed as a comparative study; therefore, 
the data were summarised using descriptive statistics (includ-
ing age at diagnosis, tumour location, tumour histology and 
adjuvant treatment). Medians and interquartile ranges were 
used to summarise continuous data because of the small num-
ber of observations. For categorical data, counts are reported. 
The SARA and the BARS demonstrated similar patterns, and 
as the SARA is more widely used in clinical paediatrics, fur-
ther analysis regarding ataxia was undertaken using the SARA 
only.
Patterns of change in outcome measures were therefore 
explored graphically (using Box-Whisker plots and time series 
plots) for the SARA and the PEDI-m. Participants were strati-
fied by putative predictive factors of tumour histology (medul-
loblastoma versus low-grade glioma), tumour location and 
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adjuvant treatment The PEDI is normative-referenced between 
6 months and 7.5 years. In line with recommendations, raw 
scores were converted to scaled scores to enable the use of the 
PEDI-m in children over the age of 7.5 years.
Results
Study sample
Thirty-five participants were recruited to the study. Par-
ticipant characteristics are detailed in Table 1.
Ataxia outcome measures
Descriptive analysis of the outcome measures is presented in 
Table 2. The SARA range at baseline was 0 to 35.5. The BARS 
range at baseline was 0 to 25. A higher SARA (out of 40) and 
BARS score (out of 30) represents more severe ataxia. The 
SARA and BARS scores were in agreement demonstrating a 
similar trend and therefore for the rest of the results as detailed 
in the data analysis plan, only the SARA is presented along-
side the PEDI-m. The PEDI-m range at baseline was 15.2–100 
(higher score representing better functional mobility, maxi-
mum score 100). A ceiling effect of the PEDI-m is noted with 
39% of children reaching the maximum score of 100 at 1 year 
post-operatively
Twenty-two children were also assessed pre-operatively 
using the SARA scale. There was an initial increase in 
SARA post-operatively (worsening ataxia) followed by 
improvement on average for the group. The ataxia scores at 
3 months post-operatively are lower (better) than the pre-
operative assessment scores, indicating improvement in 
ataxia 3 months after surgery. At 2 years post-operatively, 
ataxia severity had reduced by half of the pre-operative 
level (median values for the overall sub-group).
The change in Bal-SARA represents a large propor-
tion of the initial change in SARA score. The Bal-SARA 
includes gait, stance and sitting items of the SARA scale.
Effect of tumour location
Further analysis is completed to compare change over time 
for outcome measures dependent on tumour location (Fig. 1). 
Alternative graphical representation of line graphs for Figs. 1, 
2 and 3 are available in supplementary material (Online 
Resource 1).
A similar trajectory for both tumour locations was noted; 
however, children with unilateral tumours demonstrated lower 
SARA scores than those with midline tumours, indicating 
less ataxia throughout all time points. The change in PEDI-m 
scores demonstrated the same trajectory as previously noted, 
with rapid increase in scores between baseline and 3 months, 
although there is less difference in scores between tumour 
location. The ceiling effect of the PEDI-m is observed.
Further analysis of ataxia considering a more detailed 
breakdown of tumour location (4th ventricle, 4th ventricle/
cerebello-pontine (CP) angle, CP angle, cerebellar hemisphere 
and brain stem) is detailed in supplementary material (Online 
Resource 2). No firm conclusions can be made due to small 
numbers in each group; however, this classification may be 
of value in a larger population to identify further the effect of 
tumour location.
Effect of tumour histology
Further analysis was completed to determine whether changes 
in outcome measure score were dependent on tumour histol-
ogy. The two most common tumour histologies, medulloblas-
toma (n = 11) versus low-grade glioma (n = 17), are presented 
for all assessment timepoints.
Although both tumour types follow a similar trajectory, i.e. 
rapid drop in ataxia from baseline to 3 months post-operatively, 
children with medulloblastoma had higher SARA scores 
(more severe ataxia) and lower PEDI-m scores (more mobil-
ity function impairment) than children with low-grade gliomas 
(Fig. 2). The gap in ataxia scores appears to widen after 1 year; 
children with medulloblastoma had higher ataxia severity at 
2 years post-operatively. It is noted that the gap between the 
tumour histology groups is wider than the graphs comparing 
tumour location.





Age at time of recruitment (years)
 Median (range) 9 (4-15)
Histology (n)
 Low-grade glioma 17
 Medulloblastoma 11
 Ependymoma 4






 Surgery and radiotherapy 5
 Surgery and radiotherapy and chemotherapy 11
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Both the SARA and PEDI-m appear to be able to distin-
guish between the two tumour types. Again, there is a ceiling 
effect for the PEDI-m.
Effect of adjuvant treatment
Further analysis was completed to determine whether changes 
in outcome measure were dependent on adjuvant treatment. 
Surgery only (n = 19) versus surgery and radiotherapy (n = 5) 
versus surgery, radiotherapy and chemotherapy (n = 11) are 
presented.
A reduction in ataxia is observed for all three groups. 
However, following the 3-month assessment children who 
had received surgery, radiotherapy and chemotherapy dem-
onstrated sustained higher ataxia scores up to 2 years post-
operatively. It should be noted that only 5 children are in the 
surgery and radiotherapy group.
Effect of surgical approach
Further analysis was completed to determine whether 
changes in outcome measure were dependent on surgi-
cal approach. This is presented in supplementary material 
(Online Resource 2).
Individual change scores
There was a large range in individual change scores highlight-
ing individual variability. Individual change scores are pre-
sented further in supplementary material (Online Resource 2).
Risk factors for persistent ataxia
Further analysis regarding risk factors for persistent ataxia 
(dentate nucleus invasion, cerebellar peduncle involve-
ment, brain stem invasion and presence of hydrocephalus) 
Table 2  Participant ataxia and mobility scores
Pre-operative 
score n = 22
Baseline n = 35 3 months n = 31(n = 
4 missing)
1 year n = 33 (n = 1 
missing, n = 1 died)
2 year n = 31 (n = 2 
missing, n = 2 died)
SARA 
Group median (IQR) 6 (8.5) 8.5 (9.5) 5 (4.5) 3 (6) 2.5 (5)
range (0–24) 0–35.5 0–30 0–28.5 0–16.5
Bal-SARA 
Group median (IQR) 3 (5.25) 5 (5) 2 (2) 1 (3) 1 (3)
range 0–16 0–18 0–17 0–16 0–8
BARS
Group median (IQR) 7 (10.5) 3 (3.25) 3 (5) 2 (5)
Range 0–25 0–24 0–24 0–16
PEDI-m
Group median (IQR) 54.75 (30.9) 91.7 (20.2) 94.2 (20.2) 100 (16.15)
range 15.2–100 20.9–100 30.6–100 47–100
Fig. 1  Group median SARA 
and PEDI-m scores for children 
(n = 35), dependent upon 
tumour location. All available 
scores plotted, n=23 midline, 
n=12 unilateral. Pre op SARA 
available for n=22
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is presented in supplementary material (Online Resource 
2). Analysis was carried out to determine if the presence 
of these factors raised the risk of moderate/severe ataxia 
(defined as SARA score greater than 7, [13]) at 12 months 
post-operatively. No clear risk factors are identified, 
although caution should be applied in interpreting these 
results due to low numbers in each group.
Discussion
This is the largest published longitudinal study to focus spe-
cifically on ataxia in children with PFT and the first to report 
the course of ataxia up to 2 years after surgery including pre- 
and post-operative scores. Putative factors (tumour histology, 
location and adjuvant treatment) that may predict the severity 
and course of long-term ataxia were also identified.
The most rapid improvement in ataxia was noted in the first 
three post-operative months. Much smaller change was noted 
thereafter up to 2 years post-operatively. Although the mini-
mally clinically important difference (MCID) for the SARA 
in children has not been determined, the MCID for adults has 
been reported as 1.1 [17]. The MCID might be higher in chil-
dren with increased variability in performance (particularly 
in younger children); however, the group median change was 
more than three times the adult suggested value (3.5 between 
baseline and three months post-operatively), which highlights 
the potential clinical significance of this change. A threshold 
of change of 2.0 or more in SARA has been suggested to 
allow for physiological fluctuation in healthy children [14]. 
The change seen in this study is higher than this. The Bal-
SARA subset appears to account for a large proportion of this 
change, indicating that balance in particular rather than limb 
coordination improves in the initial post-operative period.
For the PEDI-m, a rapid improvement in mobility was also 
noted at the 3-month assessment (exceeding the MCID sug-
gested by Iyer et al. [18] of 11%), followed by minimal change 
after this point, although a ceiling effect for the PEDI-m was 
noted in this population (13 of the children scored a maxi-
mum of 100 at 1 year post-operatively). This means ongoing 
higher level mobility problems may not be detected by this 
tool. Caregiver assistance scores for the PEDI could be used 
in future studies as this might highlight more subtle change, 
such as the child being able to do a task with less assistance, 
which might have a meaningful impact on family life. Future 
research might usefully consider alternative outcome meas-
ures examining balance impairment such as the paediatric 
balance scale [19] and measures of participation.
Analysis of a subset of children who were assessed pre-
operatively demonstrated an initial increase in ataxia post-
operatively, followed by a drop below the pre-operative level 
by the 3-month assessment time point. Although it is known 
Fig. 2  Group median scores 
of SARA and PEDI-m scores 
for children (n = 28), depend-
ent upon tumour histology. All 
available scores plotted, n=17 
LGG, n=11 medulloblastoma. 
Pre op SARA for n=19
Fig. 3  Group median scores of 
SARA and PEDI-m scores for 
children (n = 35), dependent 
upon adjuvant treatment
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that approximately 60% of children will present with ataxia 
pre-operatively [4], this is the first time that the change dur-
ing this time period has been quantified, and it would be of 
value to confirm these findings with a larger sample.
SARA scores are age-dependent in healthy children [14, 
20]. However, due to the small number of participants in this 
study, it was not possible to consider age formally as a con-
founding factor in the analysis. Although children may not 
reach the adult optimum for the SARA (and BARS) scores 
until the age of 10, Lawerman et al. [14] suggested that the 
median total SARA score is under 1.5 in healthy children from 
age 6 to 10 years. Additionally, between each age year incre-
ment, only a small decrease of 0.5–1 is expected on the SARA 
(e.g. median SARA score in healthy 6 year olds is 1.5, in 7 
year olds, 0.5). This would suggest that the large changes seen 
in the first 3 months following surgery are consistent with 
recovery and repair of brain function and not just age-related 
maturational changes which occur over a longer time course.
The pattern of change reported in this study is supported 
by results from a longitudinal study which measured func-
tion in 12 children with PFT (age 6–17 years) who were 
followed up to 1 year postoperatively [9]. A reduction in 
ataxia score was observed (using the International Coop-
erative Ataxia Rating Scale ICARS) from the acute post-
operative period to 1 year after surgery, with a statistically 
significant reduction in the first 3 months, but not from 3 
months to 1 year, similar to findings from our study. Kuper 
et al. [9] observed an improvement between 3 months and 
1 year after surgery in upper limb motor function and body 
sway measured using instrumented motion analysis.
Kuper et al. [9] suggested that reduction in oedema affect-
ing the deep cerebellar nuclei was a predictor of early func-
tional recovery. If the resolution of oedema happens over 
days to weeks, an additional assessment time point at 1 
month could demonstrate if the time of most rapid change 
(improvement) corresponds with the expected resolution of 
oedema. If this is not demonstrated, other mechanisms such 
as axonal sprouting and long-term potentiation would need 
to be considered to explain recovery in the first three months 
(acute phase). The recovery trajectory identified in the pre-
sent study is consistent with studies of children with acquired 
brain injury (from other pathologies) which also indicate that 
the most rapid change occurs in the first 6-month post neu-
rological insult [21]. Further examination of potential risk 
factors for persistent ataxia, e.g. dentate nucleus invasion, 
cerebellar peduncle involvement, brainstem invasion and 
hydrocephalus, would be of value with a larger population 
to provide further prognostic information.
Children with medulloblastoma and those with midline 
tumours demonstrated higher ataxia scores (and lower func-
tional mobility scores) throughout the trajectory of their recov-
ery. This is in line with other studies reporting that children 
with medulloblastoma have a higher incidence of ataxia and 
cerebellar mutism syndrome than children with other tumour 
types [5, 22–25]. In contrast, children with low-grade gliomas 
(LGG) (predominantly pilocytic astrocytomas) typically demon-
strated lower ataxia scores. These findings are further supported 
by research that reports children with LGG most often have mild 
cerebellar dysfunction [26].
It is difficult to determine the influence of tumour histology 
compared with tumour location on ataxia severity, as there is 
an inherent link between the two factors: medulloblastoma 
more often being midline than lateralised in the cerebellum 
and LGG showing the converse relationship. Lesions to the 
deep cerebellar nuclei and inferior vermis, which are struc-
tures at or close to the midline, and the involvement of the 
efferent cerebello-thalamo-cerebral tract have been linked 
with persistent motor deficit in children [10, 24, 27]. Further 
detailed analysis regarding tumour location has been proposed 
in this study; however, due to small numbers, no conclusions 
were able to be made at this time. Future research should 
consider utilising detailed imaging of specific tumour loca-
tion, cerebellar and tumour volume as predictors of sever-
ity of ataxia. Additionally, no clear observations were able 
to be made about the impact of surgical approach on ataxia 
in this study; however, this may be of interest with a larger 
population.
Findings from this study show a wider gap in ataxia scores 
depending on tumour histology than observed due to tumour 
location, suggesting that histology differentiates the strata of 
participants better than tumour location. Despite not being 
independent factors, this indicates that anatomical predilec-
tion of tumour histology is not the whole answer, and other 
elements should be considered, the most obvious being the 
need for adjuvant oncology treatment, i.e. radiotherapy and 
chemotherapy for children with medulloblastomas. The results 
showed that children who had received both chemotherapy 
and radiotherapy demonstrated a sustained higher level of 
ataxia which is in keeping with previous research highlight-
ing the impact of chemotherapy in addition to surgery and 
radiotherapy on motor function [7]. This may explain the 
increase in SARA score for children with medulloblastoma 
after 3 months as typically, a 6-week course of radiotherapy 
is commenced within 1 month of surgery, and maintenance 
chemotherapy begins 6 weeks following this. Peripheral neu-
ropathy which is a known side effect of chemotherapy can 
impair postural control strategies and result in functional bal-
ance problems [28].
Overall, tumour location, histology and adjuvant treatment 
are all interlinked, e.g. children with medulloblastoma because 
of the nature of the tumour type typically feature midline 
tumours and receive multimodal therapy (i.e. surgery, radio-
therapy and chemotherapy). Therefore, in the future, a larger 
study which includes multivariate analysis would be of benefit 
to identify the impact of single variables to determine if any 
particular factor raises the risk of ataxia severity.
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The small number of children with severe ataxia (SARA 
greater than 14 [13]) in this study meant it was not possible to 
compare the pattern of change across the trajectories of chil-
dren with severe ataxia with those with mild/moderate ataxia. 
This analysis should be undertaken in future research to deter-
mine if there is any difference in recovery. Mapping individual 
trajectories (as in supplementary material, Online Resource 2) 
with a larger dataset might also be of value to identify char-
acteristics of participants who show potential for ongoing 
improvement and to help focus rehabilitation interventions. 
Identifying children who have less potential to improve would 
also be of value in counselling families. It is acknowledged 
that during their initial inpatient stay, children had access to 
daily rehabilitation by the same therapy team; however, follow-
ing discharge, rehabilitation intensity varied according to the 
child’s need and the availability of local services. Therefore, 
reviewing intensity of rehabilitation alongside trajectory of 
change may also be of interest.
This is the largest study to date reporting longitudinal ataxia 
severity in children with PFT. The strengths of this study 
include a prospective design using standardised validated 
outcome measures [13] over a 2-year period. The number of 
participants remains relatively small particularly for subgroup 
analysis. A further limitation is that the children were recruited 
from one tertiary site.
Our study provides information about the long-term 
course of ataxia in children following surgical resection 
for PFT. Children often have worse ataxia after surgery, 
before improving to better than they were prior to surgery. 
Children with medulloblastoma and midline tumours have 
more long-term balance and coordination problems com-
pared to children with LGG or unilateral tumours. The 
most rapid improvement was seen in the first 3 months 
postoperatively followed by a small change up to 2 years 
post-operatively. Any late changes do not appear to be 
explained simply by developmental maturation of cerebel-
lar function especially in adolescents, though the impact 
of age should be examined further.
Although the findings would benefit from further confir-
mation with a larger dataset, they demonstrate the need to 
examine the potential of targeted rehabilitation interventions 
more than 1 year post-operatively when some children other-
wise typically appear to demonstrate minimal change.
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